Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica: Implication for Cellular Immune Responses.
Patients' experiences of health and social care in long-term neurological conditions in England: a cross-sectional survey.
Optical coherence tomography and its use in optical neuritis and multiple sclerosis.
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer.
Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Generation and characterization of a novel recombinant antibody against 15-ketocholestane isolated by phage-display.
Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets.
[Vitamin D tweets light to genes in multiple sclerosis].
Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis.
Multiple sclerosis in children and adolescents: incidence and clinical picture - new insights from the nationwide German surveillance (2009-2011).
Longitudinal study of alexithymia and multiple sclerosis.
Validation of a new quality of life scale related to multiple sclerosis and relapses.
The long-term cost-effectiveness of the use of Functional Electrical Stimulation for the correction of dropped foot due to upper motor neuron lesion.
Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Neurologic complications of influenza.
Effects of physiotherapy interventions on balance in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials.
Pattern of Uveitis in an Egyptian Population with Multiple Sclerosis: A Hospital-Based Study.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.
Aggressive multiple sclerosis: proposed definition and treatment algorithm.
Protective Effects of 7,8-Dihydroxyflavone on Retinal Ganglion and RGC-5 Cells Against Excitotoxic and Oxidative Stress.
Pages
« first
‹ previous
…
237
238
239
240
241
242
243
244
245
…
next ›
last »